In hemodialysis patients, blood pressure management should prioritize volume control and utilize out-of-office blood pressure monitoring, highlighting the need for clinical trials to establish evidence-based targets.
Answers are grounded in this paper and cite their sources.
Supports volume-focused management with out-of-office BP monitoring in hemodialysis; leaves open optimal targets pending randomized trials.
PURPOSE OF REVIEW: To review recent developments in the field of hypertension in hemodialysis patients. RECENT FINDINGS: Despite the fact that hypertension is the most common complication of end-stage kidney disease, no evidence-based blood pressure (BP) targets exist for hemodialysis patients. There is growing evidence that outcomes are better predicted by out-of-office BP values, such as home or ambulatory BP monitoring. Intradialytic hypertension is associated with increased risk of death or hospitalization, and is probably mediated by volume overload. BP management should focus on volume control: dry weight 'probing' is well tolerated and effective in lowering BP, as are other strategies that minimize expansion of the extracellular fluid volume, such as avoidance of hypernatric dialysate. We discuss each of these issues in our review. SUMMARY: Modest advances in the understanding of hypertension have occurred in the past 2 years. Clinical trials that focus on BP targets and treatment choices are essential to guide future practice.
No takes yet. Share an insight, caveat, or question.
Peixoto et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: